Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers.

RATIONALE AND OBJECTIVES Computed tomography (CT) of the chest can be used to assess pectoralis muscle area (PMA) and subcutaneous adipose tissue (SAT) area. Adipose tissue content is associated with inflammatory mediators in chronic obstructive pulmonary disease (COPD) subjects. Based on gender differences in body composition, we aimed to assess the hypothesis that in subjects with COPD, the relationships between PMA, SAT, and blood biomarkers of inflammation differ by gender. MATERIALS AND METHODS We compared chest CT measures of PMA and SAT on a single slice at aortic arch and supraesternal notch levels from 73 subjects (28 women) with COPD between genders. The relationships of PMA and SAT area to biomarkers were assessed using within-gender regression models. RESULTS Women had a lesser PMA and a greater SAT area than men (difference range for PMA, 13.3-22.8 cm²; for SAT, 11.8-12.4 cm²; P < .05 for all comparisons) at both anatomic levels. These differences in PMA and SAT remained significant after adjustment for age and body mass index. Within-gender regression models adjusted for age showed that SAT was directly associated with C-reactive protein (for aortic arch level, P = .04) and fibrinogen (for both anatomic locations, P = .003) only in women, whereas PMA was not associated with any biomarkers in either gender. CONCLUSIONS It appears that in subjects with COPD, there are gender-based differences in the relationships between subcutaneous adipose tissue and inflammatory biomarkers.

[1]  F. Maltais,et al.  The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD , 2010, BMC pulmonary medicine.

[2]  K. Joshi,et al.  Evaluation of HS-CRP and Lipid Profile in COPD. , 2013, Journal of clinical and diagnostic research : JCDR.

[3]  Renata Ferrari,et al.  Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease , 2013, Respiratory Research.

[4]  B. Nordestgaard,et al.  Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. , 2013, JAMA.

[5]  L. Edwards,et al.  CT‐measured bone attenuation in patients with chronic obstructive pulmonary disease: Relation to clinical features and outcomes , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  M. Kovarik,et al.  Skinfold Anthropometry –The Accurate Method for Fat Free Mass Measurement in COPD , 2013, COPD.

[7]  Raúl San José Estépar,et al.  Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. , 2014, Annals of the American Thoracic Society.

[8]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[9]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.

[10]  Sally J. Singh,et al.  Bedside methods versus dual energy X‐ray absorptiometry for body composition measurement in COPD , 2002, European Respiratory Journal.

[11]  R. Casaburi,et al.  Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease: Do They Influence Patient-Related Outcomes? , 2013, Annals of Nutrition and Metabolism.

[12]  Y. Kang,et al.  Body mass index and fat free mass index in obstructive lung disease in Korea. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  D. Mannino,et al.  Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. , 2013, Chest.

[14]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[16]  S. Keinänen-Kiukaanniemi,et al.  Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. , 2008, American journal of preventive medicine.

[17]  Y. Lacasse,et al.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[18]  D. Mannino,et al.  Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease , 2012, Thorax.

[19]  E. Wouters,et al.  Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. , 2011, Respiratory medicine.

[20]  S. Bojesen,et al.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[21]  George R Washko,et al.  CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. , 2013, Respiratory medicine.

[22]  W. MacNee,et al.  Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.

[23]  J. Murabito,et al.  Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress: The Framingham Heart Study , 2007, Circulation.

[24]  G. Wesseling,et al.  Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. , 2011, The American journal of clinical nutrition.

[25]  D. Mannino,et al.  Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. , 2003, The American journal of medicine.

[26]  J Moxham,et al.  Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD , 2009, Thorax.

[27]  L. Edwards,et al.  Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.

[28]  E. Wouters,et al.  Body composition and mortality in chronic obstructive pulmonary disease. , 2005, American Journal of Clinical Nutrition.